Literature DB >> 29264763

Suppression of Disheveled-Axin Domain Containing 1 (DIXDC1) by MicroRNA-186 Inhibits the Proliferation and Invasion of Retinoblastoma Cells.

Xuanyi Che1,2, Yuanjie Qian3, Di Li4.   

Abstract

Recent evidence shows that Disheveled-Axin domain containing 1 (DIXDC1) is dysregulated in various cancers. However, the role of DIXDC1 in retinoblastoma (RB) remains unclear. In this study, we aimed to investigate the biological function of DIDXDC1 in RB and the way in which its expression is regulated by microRNAs (miRNAs). We found that DIXDC1 expression was significantly upregulated in RB cell lines. The silencing of DIXDC1 by small interfering RNA (siRNA) significantly inhibited the proliferation, invasion, and Wnt signaling in RB cell lines. Interestingly, DIXDC1 was identified as a target gene of miR-186. The expression of DIXDC1 was negatively regulated by miR-186, and DIXDC1 expression was inversely correlated with miR-186 expression in RB clinical specimens. Overexpression of miR-186 inhibited the proliferation, invasion, and Wnt signaling in RB cell lines. Moreover, overexpression of DIXDC1 markedly reversed the antitumor effect of miR-186. Overall, our results reveal that DIXDC1 functions as a potential oncogene in RB, and inhibiting DIXDC1 by miR-186 suppresses the proliferation and invasion of RB cell lines. Our study suggests that DIXDC1 and miR-186 may serve as novel therapeutic targets for the treatment of RB.

Entities:  

Keywords:  DIXDC1; Retinoblastoma; Wnt; miR-186

Mesh:

Substances:

Year:  2017        PMID: 29264763     DOI: 10.1007/s12031-017-1017-7

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  51 in total

1.  DIXDC1 co-localizes and interacts with gamma-tubulin in HEK293 cells.

Authors:  Yanrui Wu; Xiaotang Jing; Xin Ma; Yan Wu; Xuefeng Ding; Wenhong Fan; Ming Fan
Journal:  Cell Biol Int       Date:  2009-04-16       Impact factor: 3.612

2.  miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin.

Authors:  X Zhu; H Shen; X Yin; L Long; C Xie; Y Liu; L Hui; X Lin; Y Fang; Y Cao; Y Xu; M Li; W Xu; Y Li
Journal:  Oncogene       Date:  2015-04-13       Impact factor: 9.867

3.  MiR-433 inhibits retinoblastoma malignancy by suppressing Notch1 and PAX6 expression.

Authors:  Xiaohua Li; Lan Yang; Tianjiao Shuai; Tianhua Piao; Rui Wang
Journal:  Biomed Pharmacother       Date:  2016-05-13       Impact factor: 6.529

4.  MiR-613 suppresses retinoblastoma cell proliferation, invasion, and tumor formation by targeting E2F5.

Authors:  Yiting Zhang; Xinyue Zhu; Xiaomin Zhu; Yan Wu; Yajun Liu; Borui Yao; Zhenping Huang
Journal:  Tumour Biol       Date:  2017-03

5.  DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation.

Authors:  Lei Wang; Xi-Xi Cao; Qi Chen; Teng-Fang Zhu; Hong-Guang Zhu; Li Zheng
Journal:  Cancer Sci       Date:  2009-06-17       Impact factor: 6.716

6.  microRNA-186 inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma by targeting SKP2.

Authors:  Wei He; Jianfang Feng; Yan Zhang; Yuanyuan Wang; Wenqiao Zang; Guoqiang Zhao
Journal:  Lab Invest       Date:  2015-11-16       Impact factor: 5.662

Review 7.  MicroRNAs: Oncogenes, tumor suppressors or master regulators of cancer heterogeneity?

Authors:  P Mathijs Voorhoeve
Journal:  Biochim Biophys Acta       Date:  2009-09-10

8.  Upregulated expression of DIXDC1 in intestinal-type gastric carcinoma: co-localization with β-catenin and correlation with poor prognosis.

Authors:  Lei Wang; Cong Tan; Fan Qiao; Weige Wang; Xiangnan Jiang; Peng Lian; Bin Chang; Weiqi Sheng
Journal:  Cancer Cell Int       Date:  2015-12-18       Impact factor: 5.722

9.  Huaier aqueous extract inhibits ovarian cancer cell motility via the AKT/GSK3β/β-catenin pathway.

Authors:  Xiaohui Yan; Tianjiao Lyu; Nan Jia; Yinhua Yu; Keqin Hua; Weiwei Feng
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

10.  The effect of ROCK-1 activity change on the adhesive and invasive ability of Y79 retinoblastoma cells.

Authors:  Jing Wang; Xiao-Hong Liu; Zi-Jian Yang; Bing Xie; Yi-Sheng Zhong
Journal:  BMC Cancer       Date:  2014-02-14       Impact factor: 4.430

View more
  4 in total

Review 1.  Expression profiles and prognostic value of miRNAs in retinoblastoma.

Authors:  Lara Elis Alberici Delsin; Karina Bezerra Salomao; Julia Alejandra Pezuk; Maria Sol Brassesco
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-22       Impact factor: 4.553

2.  Metabolic/hypoxial axis predicts tamoxifen resistance in breast cancer.

Authors:  Hany N Azzam; Marwa O El-Derany; Sara A Wahdan; Reham M Faheim; Gouda K Helal; Ebtehal El-Demerdash
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

Review 3.  Non-Coding RNAs in Retinoblastoma.

Authors:  Meropi Plousiou; Ivan Vannini
Journal:  Front Genet       Date:  2019-11-14       Impact factor: 4.599

Review 4.  The Dual Role of miR-186 in Cancers: Oncomir Battling With Tumor Suppressor miRNA.

Authors:  Ying Xiang; Qing Tian; Li Guan; Shuai-Shuai Niu
Journal:  Front Oncol       Date:  2020-03-05       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.